1.96

6.22% -0.13

Pre-market: 1.92 -0.04 -2.04%

Sana Biotechnology Inc (SANA)

Overview News Price History Option Chain Financials Why SANA Down? Discussions Forecast

Sana Biotechnology Inc stock is traded at $1.96, with a volume of 4.87M. It is down -6.22% in the last 24 hours and up +23.27% over the past month. Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

Previous Close:

$2.09

Open:

$2.075

24h Volume:

4.87M

Relative Volume:

1.42

Market Cap:

$442.10M

Revenue:

Net Income/Loss:

$-283.26M

P/E Ratio:

-1.3333

EPS:

-1.47

Net Cash Flow:

$-273.61M

1W Performance:

+10.11%

1M Performance:

+23.27%

6M Performance:

-16.60%

1Y Performance:

-76.39%

1-Day Range:

$1.90

$2.075

1-Week Range:

$1.60

$2.0999

52-Week Range:

$1.26

$8.51

Sana Biotechnology Inc Stock (SANA) Company Profile

Name

Sana Biotechnology Inc

Sector

Healthcare (1173)

Industry

Biotechnology (668)

Phone

(206) 701-7914

Address

188 EAST BLAINE STREET, SUITE 400, SEATTLE

Employee

194

Twitter

Next Earnings Date

2025-03-17

Latest SEC Filings

SANA's Discussions on Twitter

Compare SANA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SANA Sana Biotechnology Inc	1.96	401.49M	0	-283.26M	-273.61M	-1.47
ONC Beigene Ltd Adr	236.49	23.78B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	435.32	108.15B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.24	43.44M	0	0	0	0.00
REGN Regeneron Pharmaceuticals Inc	604.62	61.69B	14.09B	4.50B	2.96B	39.28
VRNA Verona Pharma Plc Adr	74.09	5.72B	0	-153.72M	-103.81M	-2.00

Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-18-25	Upgrade	Citizens JMP	Mkt Perform → Mkt Outperform
Mar-14-25	Initiated	Jefferies	Buy
Jan-08-25	Upgrade	TD Cowen	Hold → Buy
Nov-05-24	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Jun-26-24	Initiated	Rodman & Renshaw	Buy
Jan-16-24	Upgrade	H.C. Wainwright	Neutral → Buy
Sep-25-23	Initiated	JMP Securities	Mkt Outperform
Sep-05-23	Initiated	Citigroup	Buy
Aug-14-23	Initiated	TD Cowen	Market Perform
May-02-23	Initiated	H.C. Wainwright	Neutral
Mar-01-21	Initiated	BofA Securities	Buy
Mar-01-21	Initiated	Goldman	Neutral
Mar-01-21	Initiated	JP Morgan	Neutral
Mar-01-21	Initiated	Morgan Stanley	Overweight

View All

Sana Biotechnology Inc Stock (SANA) Latest News

May 20, 2025

SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

May 20, 2025

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - Business Wire

May 20, 2025

Levi & Korsinsky Notifies Shareholders of Sana Biotechnology, Inc.(SANA) of a Class Action Lawsuit and an Upcoming Deadline - Morningstar

May 20, 2025

May 19, 2025

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - StreetInsider

May 19, 2025

Sana: HIP-Modified Islet Cells To Possibly Change Scope Of Type 1 Diabetes Treatment - Seeking Alpha

May 19, 2025

Shareholders of Sana Biotechnology, Inc. Should Contact Levi & Korsinsky Before May 20, ... - Eagle-Tribune

May 19, 2025

SANA DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, - GlobeNewswire

May 19, 2025

Sana Biotechnology, Inc. Sued for Securities Law ViolationsContact The Gross Law Firm Before May 20, 2025 to Discuss Your RightsSANA - marketscreener.com

May 19, 2025

The End Of The Diabetes Industry?Eli Lilly (NYSE:LLY), DexCom (NASDAQ:DXCM) - Benzinga

May 19, 2025

SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm - marketscreener.com

May 19, 2025

Join Class Action to Recover Losses from Sana Biotechnology, Inc. (SANA)Contact Levi & Korsinsky Before May 20, 2025 - ACCESS Newswire

May 19, 2025

May 18, 2025

Contact Levi & Korsinsky by May 20, 2025 to Join Class Action Against Sana Biotechnology, Inc. (SANA) - ACCESS Newswire

May 18, 2025

Investors in Sana Biotechnology, Inc. (SANA): Protect Your RightsContact Levi & Korsinsky Before May 20, 2025 - ACCESS Newswire

May 18, 2025

SANA Investors Have the Opportunity to Lead the Sana Biotechnology Securities Fraud Lawsuit ... - Bluefield Daily Telegraph

May 18, 2025

SANA Investors Have the Opportunity to Lead the Sana Biotechnology Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - Morningstar

May 18, 2025

May 17, 2025

2025-05-17 | Securities Class Action Lawsuit Filed Against Sana Biotechnology, Inc. (SANA)Levi & Korsinsky Represents Shareholders | NDAQ:SANA | Press Release - Stockhouse

May 17, 2025

SANA Deadline: Rosen Law Firm Urges Sana Biotechnology, Inc. (NASDAQ: SANA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - Business Wire

May 17, 2025

SANA Deadline: SANA Investors with Losses in Excess of $100K Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit - PR Newswire

May 17, 2025

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - StreetInsider

May 17, 2025

May 16, 2025

2025-05-16 | Join Class Action to Recover Losses from Sana Biotechnology, Inc. (SANA)Contact Levi & Korsinsky Before May 20, 2025 | NDAQ:SANA | Press Release - Stockhouse

May 16, 2025